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Abstract Killer yeasts secrete proteinaceous killer toxins
lethal to susceptible yeast strains. These toxins have no
activity against microorganisms other than yeasts, and
the killer strains are insensitive to their own toxins.
Killer toxins diﬀer between species or strains, showing
diverse characteristics in terms of structural genes, mo-
lecular size, mature structure and immunity. The
mechanisms of recognizing and killing sensitive cells
diﬀer for each toxin. Killer yeasts and their toxins have
many potential applications in environmental, medical
and industrial biotechnology. They are also suitable to
study the mechanisms of protein processing and secre-
tion, and toxin interaction with sensitive cells. This re-
view focuses on the biological diversity of the killer
toxins described up to now and their potential biotech-
nological applications.
Keywords Killer yeasts Æ Mycotoxins Æ Genetic basis Æ
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Introduction
Many yeast cultures secrete killer toxins that inhibit
growth of other yeasts strains, but to which they are
immune. Killer (K), sensitive (S), and neutral (N) phe-
notypes of Saccharomyces cerevisiae were ﬁrst described
by Makower and Bevan [16]. Killer yeasts were there-
after shown to be widespread amongst laboratory
strains. These early observations led to the search for
killer yeasts in other genera.
The assay method currently employed to distinguish
killer strains was ﬁrst described by Makower and Bevan
in 1963 [16]. Woods and Bevan reﬁned this method and
established the optimal culture conditions for toxin
production and activity [44]. The killing ability of these
compounds may be underestimated or may even remain
unnoticed depending on the selection of the appropriate
sensitive strain and other experimental conditions. For
example, the addition of sodium chloride, which en-
hances the killer phenotype of some strains, showed that
some supposedly resistant strains were sensitive to toxin
[15]. The best studied killer species is S. cerevisiae, which
secretes diﬀerent types of killer toxins.
Saccharomyces cerevisiae killer system
When the ﬁrst studies on the nature of the killing phe-
nomenon showed the involvement of cytoplasmic non-
Mendelian genetic determinants, the occurrence in killer
yeasts of double-stranded RNA (dsRNA) associated
with virus-like particles (VLPs) was suggested [1, 8, 19,
23, 29,37]. Saccharomyces cerevisiae killer toxins (K1,
K2 and K28) are encoded by diﬀerent satellite dsRNAs
(M1, M2 and M28) that are cytoplasmically inherited
and encapsidated in virus-like particles. For their repli-
cation and encapsidation, another group of helper yeast
viruses (L-A) is needed [30, 34, 42,43]. These well-char-
acterised dsRNA viruses are members of the family
Totiviridae. The presence of a satellite M dsRNA in cells
coinfected with an L-A virus is responsible for the killer-
immune phenotype observed in the killer strains [2,45].
A single open reading frame encodes the toxin, which
is synthesized as a single polypeptide pre-protoxin
comprising hydrophobic amino termini larger than
those usually found on secreted proteins and potential
kex1/kex2 cleavage and N-linked glycosilation sites. The
pre-protoxin, once synthesized, undergoes post-transla-
tional modiﬁcations via the endoplasmic reticulum,
Golgi apparatus, and secretory vesicles, resulting in
the secretion of the mature, active toxin (Fig. 1). The
N-terminal leader directs the precursor protein to the
endoplasmic reticulum functioning as a conventional
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signal sequence. This molecule is a protoxin that has
been shown to be converted into a 34 kDa species by the
action of endoglycosidase H; therefore, it is a glyco-
protein. Glycosylation is necessary for the eﬃcient se-
cretion of toxin [3]. The active K1 killer toxin, however,
is not glycosylated; thus the glycosylated portion must
be removed during the toxin maturation process. The
34 kDa protoxin contains all peptide components of the
K1 killer toxin. When the protoxin passes through
the Golgi apparatus, a proteolytic cleavage occurs, and
both a and the b disulﬁde-linked toxins form and are
released by fusion with the plasma membrane. When the
toxin has been secreted from the plasma membrane,
two processes reduce the amount of toxin present
in the extracellular medium: (a) the activity of
(phenylmethylsulfonylﬂuoride-sensitive proteases from
the cell, which degrade a substantial proportion of the
secreted toxin molecules [42], and (b) the presence of
receptors for the killer toxin on the cell wall of the killer
strain. (1ﬁ6)-b-D-Glucan in the cell wall plays a major
role in the toxin’s binding to sensitive cells [9, 27,28].
Killer cells are immune, but have these linkages. Some
secreted toxin is bound and is not found in the medium.
As described above, the K1 killer toxin secreted by
S. cerevisiae consists of a disulﬁde-linked a-b dimer.
Both subunits have a relatively high content of charged
and hydrophobic amino acids. The excess charge of
toxin (pI=4.5) resides in the b subunit. The toxin is
capable of forming multimers of the basic dimer. Some
studies have described the presence of multimers up to
octamers; it is not clear, however, whether these multi-
mers are necessary for toxin action. Based on the dimeric
structure of the killer toxin, several modes of action are
possible. The most widely accepted model suggests that
the a-subunit, with two hydrophobic, potentially mem-
brane-spanning domains, is a candidate for the channel
domain. This subunit might provide the proton-binding
sites for the cation channels produced by toxin in target
cell membranes. In this model, the b-subunit is involved
in cell-wall receptor binding [18] (Fig. 2).
Other killer toxins
The major killer strains of S. cerevisiae belong to the
killer classes K1 and K2, which kill each other, but are
immune to killer toxins of their own class. The activity
of K1 killer remains stable within a narrow range of
acidic pH, is unstable at temperatures above 25 C, and
can be inactivated by agitation. Soon after the dis-
covery of this phenomenon it became obvious that
killer strains, in addition to not being restricted to
Saccharomyces, could also be found in other genera
Fig. 1. Outline of the structure of the K1 killer toxin-immunity
precursor and structure of the mature toxin. SP Signal peptidase,
KEX killer expression proteases involved in toxin processing, G
location of the glycosylated asparagine residues, HD hydrophobic
domains [42, 43]
Fig. 2. Receptor-mediated kill-
ing of a sensitive yeast cell by
K1 killer toxin of Saccharomy-
ces cerevisiae. After binding to
the cell wall [9], K1 killer toxin
is transferred to the cytoplasmic
membrane and acts by forming
voltage-independent cationic
transmembrane channels, which
cause ion leakage and subse-
quent cell death. The existence
of a receptor (R) in the mem-
brane has been postulated
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including Candida, Cryptococcus, Debaryomyces,
Hanseniaspora, Kluyveromyces, Pichia, Sporidiobolus,
Tilletiopsis and Zygosaccharomyces (Table 1). Subse-
quent studies of a variety of killer toxins showed that
the characteristics of the K1 killer toxin and other
toxins tend to be similar. Toxins from all killer strains
studied are protease-sensitive, heat-labile macromole-
cules. Most of them are stable and act only at acidic
pH values. This is the case for Cryptococcus humicola
(killer toxin active at pH 3–5.5) [6], Pichia kluyveri
(killer toxin active at pH 2.5–4.7) [27] and Pichia ino-
sitovora (killer toxin active at pH 3.4–4.2). The most
stable killer toxins are those of Hansenula mrakii (sta-
ble at pH 2–11, and unaﬀected by heating at 60 C for
1 h) [36] and H. saturnus (stable at pH 3–11, and 75%
stable at 80 C for 1 h). Similar results have been
found for Tilletiopsis albenscens killer toxin, which is
stable at pH 3.5–8 [12]. The genetic bases of killer
characters of non-Saccharomyces yeasts are quite dif-
ferent from that of the K1 system. The killer toxin of
Kluyveromyces lactis is encoded by linear dsDNA
plasmids whereas Pichia farinosa killer toxin is
chromosomally inherited [35]. Table 1 summarizes the
distribution of killer toxins among yeast species and the
genetic basis of some of the described killer toxins.
Diversity in the mode of action of killer toxins
The few toxins examined for action on S. cerevisiae
appear to act like the K1 toxin in causing plasma
membrane damage (Fig. 2). Toxins K1 and K2 are very
similar in their mode of action; nevertheless, they are
diﬀerent proteins. A sequence of two reactions explains
the activity of the K1 killer toxin of S. cerevisiae. The
ﬁrst step, the adsorption of the killer toxin to the cell-
wall receptor (1ﬁ6)-b-D-glucan, is strongly pH-depen-
dent [9, 27,28]. Although the cell-wall receptor is
necessary for toxin action, it seems not to be the only
component implicated in the killing process. At the
following step, which is energy-dependent, the killer
toxin interacts with a receptor on the plasma membrane,
which results in the membrane becoming permeable to
protons and potassium ions. These are the ﬁrst distinct
responses in sensitive cells, and are apparently due to the
killer toxin acting as a K+ ionophore or a protono-
phore. Later, the membrane becomes permeable to
molecules of higher molecular mass such as ATP.
Whether the killer toxin inhibits some component of the
proton pump or acts more directly by forming a trans-
membrane protein channel remains unclear. The am-
phipathic character of the killer toxin proteins is
consistent with the proposal that K1 killer toxin directly
disrupts the transmembrane electrochemical gradients of
the plasma membrane. Martinac et al. [18] showed that
K1 toxin could form ion channels in vivo in sensitive
spheroplasts, whereas it formed artiﬁcial liposomes
in vitro, which suggests that these channels could kill
sensitive yeast cells. The action of the killer toxin from
P. kluyveri has been examined in detail [20]. This toxin is
very similar to K1 in its action. After a lag of 50–90 min,
physiological changes in the sensitive cells are observed
in response to P. kluyveri killer toxin. Coordinated with
potassium and ATP leakage, toxin-treated cells become
more permeable to protons and intracellular pH drops,
resulting in cell death. In our laboratory, we found
similar results (unpublished) for a yeast strain isolated
from olive brines and identiﬁed as Pichia membranifac-
iens CYC 1106, a killer strain with a broad spectrum of
activity against other yeasts isolated from the same
brines [15,17]. P. membranifaciens killer toxin is active
against some sensitive strains such as Candida boidinii
IGC 3430 only in the presence of sodium chloride [15].
This peculiarity has been studied to establish the role of
NaCl in the killer character of this yeast. This killer
toxin has an aﬃnity to linear (1ﬁ6)-b-D-glucan [27], and
this is the initial step for its toxic action. Cells of
C. boidinii IGC 3430 treated with P. membranifaciens
toxin had a lag of approximately 1 h before cell death.
Metabolic events associated with the loss of C. boidinii
viability were quantitatively identical to those known to
occur with K1 killer-toxin-treated cells. Killing of sen-
sitive cells of C. boidinii was characterized by potassium
leakage, sodium inﬂux and a drop in the intracellular pH
(unpublished results).
The K28 killer toxin of S. cerevisiae diﬀers from K1
and K2 killer toxins in that it is bound to the manno-
protein part of the yeast cell wall [38]; this feature has
been used for the puriﬁcation of K28. In contrast, K28
has no such ionophoric eﬀect, but rather inhibits nuclear
DNA synthesis [31]. K28-treated cells arrest in the
budded phase of the cell cycle with an unreplicated (G1)
content of DNA in a single nucleus located in the
mother cell. Similar results have been found in K. lactis
killer toxin. The action of this toxin is not immediate,
since it must have been present continuously for more
than 1 h before aﬀecting a signiﬁcant proportion of the
treated cells. This toxin causes sensitive yeasts to arrest
proliferation as unbudded cells, which suggests that it
blocks completion of the G1 phase of the cell cycle [4].
The mechanism underlying the action of H. mrakii is
not yet well understood. Its toxin kills sensitive strains
presumably by interfering with b-(1ﬁ3)-glucan synthe-
sis. Recent studies suggest, however, that a calcium-
binding cell surface protein could be involved in the
action of this killer toxin [36].
Applications
Killer yeasts and their toxins may have several applica-
tions. They have been used as model systems to study
the mechanisms of regulation in eukaryotic polypeptide
processing, secretion and toxin interaction with sensitive
cells. Furthermore, the killer system in yeast provides
useful models for the study of the control and expression
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of eukaryotic viruses. In addition, killer systems could
have biotechnological applications both in fermentation
industries and in medicine (Table 2). In recombinant
DNA technology, killer plasmids from S. cerevisiae and
K. lactis have the potential to serve as cloning vectors for
the eﬀective secretion of expressed polypeptides [39].
Fermentation
Killer yeasts are more abundant in natural habitats
than in culture collections. The advantage that yeasts
with killer characters have over sensitive strains in the
environment can account for this abundance. Similarly,
in the fermentation industries spoilage yeasts have high
incidences of killer characters, which must also reﬂect
their competitive advantage over commercial yeasts,
most of which are sensitive to killer yeast strains [10,
29, 33,40]. In some fermentation processes, killer yeasts
compete eﬃciently with brewing yeasts, this fact being
of great importance in continuous culture. In batch
cultures, there is competition only at high levels of
contamination with the killer strain. At low levels, the
large inoculum of the brewing yeast competes eﬃciently
by consuming nutrients, which restricts the growth of
contaminant killer strains. The optimum pH for pro-
duction and stability of K1 killer toxin ranges from 4.6
to 4.8; therefore, it is not important for winemaking.
However, K2 toxin, whose optimum pH ranges from
2.9 to 4.9, might pose a threat to the wine industry; K2
killer yeast causes protracted and blocked wine fer-
mentation [40]. Pronounced killer activity occurs when
the ratios of killer and sensitive cells are similar. To
sum up, either neutral strains or killer strains having
desirable oenological properties should be preferred.
Killer yeasts could be used as starter cultures to control
the growth of contaminant yeasts during the early
stages of wine fermentation. To prevent spoilage by
undesirable strains, killer yeasts suitable for brewing
have been constructed by cytoduction [33]. The transfer
of the killer character from one strain to another is
possible without changing the nuclear genotype. Nu-
clear genotypes confer many signiﬁcant biochemical
features to industrial wine yeast strains. Protoplast fu-
sion has been employed to obtain killer yeasts with
good organoleptic properties [10].
Taxonomy
Yeasts make up a highly heterogeneous group of uni-
cellular organisms. Although several discriminative cri-
teria allow ascomycetous and basidiomycetous yeasts to
be recognized, the distinction of diﬀerent yeasts is often
diﬃcult. Molecular studies showed that many classical
features used to deﬁne taxa, such as fermentation and
assimilation of sugars, presence of spores, and mor-
phology, are of limited value. At this point, the search
for simple tests, which can be used widely, is of great
importance. One of these tests could consist of ﬁnding
out the diﬀerences in sensitivity to toxins produced by
killer yeasts that are active against yeasts taxonomically
related to killer-toxin producers [7,25]. According to the
diﬀerent sensitivities to killer toxins, it is possible to
group yeasts into categories that are reproducible even if
other characteristics are heterogeneous [6, 7, 21,25].
Medicine
Killer yeasts may have medical applications, particularly
in the biotyping of the pathogenic yeasts Candida albi-
cans and C. neoformans. The potential of these toxins as
novel antimycotic agents for the treatment of infections
has also been suggested [5,26]. Killer toxins are very
labile at physiological temperatures and pH. However,
their addition to buﬀered solutions might result in the
eﬀective treatment of yeast infections of the skin and
mucosal membranes. Killer toxins cannot be used as
systemic antibiotics because they are antigenic, as might
be expected for large foreign proteins. It was possible,
however, to obtain anti-idiotypic antibodies that exerted
the same antimicrobial activities as the corresponding
killer toxins. Polonelli et al. [26] produced these anti-
bodies, which apparently shared the active site of the
P. anomala toxin. These anti-idiotypic antibodies mim-
icked the killer eﬀect of the secreted toxin against
C. albicans.
Table 2. Potential applications of killer toxins
Biotechnological ﬁeld of application Application References
Biological control in agriculture Antifungal activity against wood-decay and plant pathogenic
fungi. Prevention of aerobic spoilage of silage.
[11, 12,41]
Beverage fermentations Avoid undesired contaminants in wine, beer, sake, etc. [10, 24, 33,40]
Cellular biology research on eukaryotic cells Studies of biosynthesis, cellular processing and secretion of proteins. [30,43]
Food technology Food preservatives of natural origin [14,22]
Genetics Selection of hybrids obtained by protoplast fusion; Fingerprinting
of wine yeasts. Recombinant DNA technology (cloning vectors)
[10, 33,39]
Medicine Zymocide activities against pathogens [5, 26,32]
Taxonomy Killer toxin sensitivity patterns may be indicative of phylogenetic
aﬃliation.
[7, 13,25]
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Conclusions
Research on killer yeasts for industrial application is
relatively new. The more strains from nature are
screened for their range of toxin activity, the better their
complex genetics, regulating mechanisms, compatibility,
and level of toxin production will be understood. This
increasing knowledge will allow the selection or con-
struction of wine, beer and other industrial yeasts with
killer activities targeted against a broad range of unde-
sirable wild-type yeasts.
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